Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors

被引：71

作者：

Feng, Song ^{[1
]}

Hong, Di ^{[1
]}

Wang, Baoxia ^{[1
]}

Zheng, Xiufang ^{[1
]}

Miao, Kun ^{[1
]}

Wang, Lisha ^{[2
]}

Yun, Hongying ^{[1
]}

Gao, Lu ^{[3
]}

Zhao, Shuhai ^{[1
]}

Shen, Hong C. ^{[1
]}

机构：

[1] Roche Innovat Ctr Shanghai, Med Chem, Shanghai 201203, Peoples R China

[2] Roche Innovat Ctr Shanghai, Mol Design & Chem Biol, Shanghai 201203, Peoples R China

[3] Roche Innovat Ctr Shanghai, Infect Dis Pharmaceut Res & Early Dev, Shanghai 201203, Peoples R China

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2015年 / 6卷 / 03期

关键词：

Respiratory syncytial virus (RSV); virus; antiviral; fusion inhibitors; imidazopyridine; heterocycle; OPTIMIZATION; INFLUENZA; ENTRY;

D O I：

10.1021/acsmedchemlett.5b00008

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of imidazolepyridine derivatives were designed and synthesized according to the established docking studies. The imidazopyridine derivatives were found to have good potency and physical-chemical properties. Several highly potent compounds such as 8ji, 8j1, and 8jm were identified with single nanomolar activities. The most potent compound 8jrn showed an IC50 of 3 nM, lower nnicrosome clearance and no CYP inhibition. The profile of 8jrn appeared to be superior to BMS433771, and supported further optimization.

引用

页码：359 / 362

页数：4

共 50 条

[41] Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors
Lu, Wenchao
Wang, Jun
Li, Yong
Tao, Hongru
Xiong, Huan
Lian, Fulin
Gao, Jing
Ma, Hongna
Lu, Tian
Zhang, Dan
Ye, Xiaoqing
Ding, Hong
Yue, Liyan
Zhang, Yuanyuan
Tang, Huanyu
Zhang, Naixia
Yang, Yaxi
Jiang, Hualiang
Chen, Kaixian
Zhou, Bing
Luo, Cheng
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 184
[42] Discovery and synthesis of triphenylethanamine derivatives as highly potent cholesteryl ester transfer protein Inhibitors
Wang, Tammy
Qiao, Jennifer
Chen, Alice Ye
Taylor, David
Yang, Richard
Sleph, Paul
Li, Julia
Li, Danshi
Chang, Ming
Chen, Xue-Qing
Xu, Carrie
Li, Jianqing
Levesque, Paul
Huang, Christine
Adam, Leonard
Salvati, Mark
Finlay, Heather
Wexler, Ruth
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
[43] Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
Dirk Roymans
Sarhad S Alnajjar
Michael B Battles
Panchan Sitthicharoenchai
Polina Furmanova-Hollenstein
Peter Rigaux
Joke Van den Berg
Leen Kwanten
Marcia Van Ginderen
Nick Verheyen
Luc Vranckx
Steffen Jaensch
Eric Arnoult
Richard Voorzaat
Jack M. Gallup
Alejandro Larios-Mora
Marjolein Crabbe
Dymphy Huntjens
Pierre Raboisson
Johannes P. Langedijk
Mark R. Ackermann
Jason S McLellan
Sandrine Vendeville
Anil Koul
Nature Communications, 8
[44] ANTIGENIC STRUCTURE OF THE FUSION GLYCOPROTEIN OF RESPIRATORY SYNCYTIAL VIRUS
PARADISO, PR
HU, B
HILDRETH, S
MARTIN, A
ARUMUGHAM, R
IMMUNOBIOLOGY OF PROTEINS AND PEPTIDES V : VACCINES: MECHANISMS, DESIGN AND APPLICATIONS, 1989, 251 : 273 - 278
[45] Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor
Roymans, Dirk
Alnajjar, Sarhad S.
Battles, Michael B.
Sitthicharoenchai, Panchan
Furmanova-Hollenstein, Polina
Rigaux, Peter
Van den Berg, Joke
Kwanten, Leen
Van Ginderen, Marcia
Verheyen, Nick
Vranckx, Luc
Jaensch, Steffen
Arnoult, Eric
Voorzaat, Richard
Gallup, Jack M.
Larios-Mora, Alejandro
Crabbe, Marjolein
Huntjens, Dymphy
Raboisson, Pierre
Langedijk, Johannes P.
Ackermann, Mark R.
McLellan, Jason S.
Vendeville, Sandrine
Koul, Anil
NATURE COMMUNICATIONS, 2017, 8
[46] PURIFICATION AND CHARACTERIZATION OF THE RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN
WALSH, EE
BRANDRISS, MW
SCHLESINGER, JJ
JOURNAL OF GENERAL VIROLOGY, 1985, 66 (MAR): : 409 - 415
[47] Orally active fusion inhibitor of respiratory syncytial virus
Cianci, C
Yu, KL
Combrink, K
Sin, N
Pearce, B
Wang, A
Civiello, R
Voss, S
Luo, GX
Kadow, K
Genovesi, EV
Venables, B
Gulgeze, H
Trehan, A
James, J
Lamb, L
Medina, I
Roach, J
Yang, Z
Zadjura, L
Colonno, R
Clark, J
Meanwell, N
Krystal, M
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 413 - 422
[48] Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein
McLellan, Jason S.
CURRENT OPINION IN VIROLOGY, 2015, 11 : 70 - 75
[49] Purification of human respiratory syncytial virus fusion glycoprotein
Zheng, Yanpeng
Tang, Yaning
Fu, Yuanhui
He, Jinsheng
Wang, Xiaobo
Hong, Tao
PROTEIN EXPRESSION AND PURIFICATION, 2012, 81 (01) : 115 - 118
[50] RFI-641, a potent respiratory syncytial virus inhibitor
Huntley, CC
Weiss, WJ
Gazumyan, A
Buklan, A
Feld, B
Hu, W
Jones, TR
Murphy, T
Nikitenko, AA
O'Hara, B
Prince, G
Quartuccio, S
Raifeld, YE
Wyde, P
O'Connell, JF
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 841 - 847

← 1 2 3 4 5 →